Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

Nε-(carboxymethyl) lysine delays hair growth by blocking a key protein.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Metformin may help treat neuroendocrine tumors.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

Melatonin stops melanin production after tyrosinase action, with cyclic GMP mimicking this effect.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

The treatments stopped hair regrowth in mice.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Iron chelators can effectively reduce hair loss and improve hair growth in autoimmune alopecia.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Neurotrophins may contribute to genetic hair thinning by inhibiting hair growth.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Jamogenin and other compounds may help treat hair loss by inhibiting 5-alpha reductase.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Antiandrogens block male hormones and are not safe during pregnancy.

Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

L-threonate may help prevent balding by blocking a key hair loss factor.

Nitrogen mustard causes DNA damage and structural changes in mouse skin hair follicles, but some recovery occurs after 5 days.